466505524
16 Oct 2021
Switzerland Ad hoc announcement pursuant to Art. 53 LR Roches anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimers disease, Switzerland
N/A
Healthcare & Medical - Medical Tenders
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.